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This review provides an overview of the inflammatory mechanisms and immunological aspects specific to
atopic dermatitis. The review discusses publications on the roles of different T-cell subsets (that is, T helper 1
(Th1), Th2, T-regulatory, and Th17 cells), myeloid and plasmacytoid dendritic cells, and eosinophils. A further
focus lies on keratinocyte–T-cell interactions, which may be of particular relevance in eczema. Mechanisms in
innate and adaptive immunity that result in susceptibility to skin infections and in hyperreactivity to
environmental stimuli, influencing the course and severity of atopic dermatitis, are summarized. Because the
Journal of Investigative Dermatology has recently published reviews of specific features of barrier defects,
defects in innate immunity, and, in this issue, genetics, these topics are only briefly discussed here in the
context of immunology of atopic dermatitis.
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INTRODUCTION
Atopic dermatitis (AD) is a chronic
inflammatory skin disease that com-
monly begins in early infancy, runs a
course of relapses and remissions,
and is associated with a characteristic
distribution and morphology of skin
lesions. Furthermore, pruritus and con-
sequent sleeplessness are hallmarks of
AD. Numerous trigger factors have
been identified for AD in recent dec-
ades, including inhaled allergens, food
allergens, irritative substances, and
infectious microorganisms, such as
Staphylococcus aureus and Malassezia
species (Werfel and Kapp, 1998; Akdis
et al., 2006; Leung et al., 2007; Bieber,
2008).
A complex interaction between sus-
ceptibility genes encoding skin barrier
molecules and markers of the inflam-
matory response, host environments,
infectious agents, and specific immu-
nologic responses are involved in the
pathophysiology of AD. In this review,
the focus is on the immunological and
inflammatory mechanisms. The immu-
nohistology of the various phases of the
disease are summarized, and the major
cells involved in cutaneous inflamma-
tion are characterized. Clearly,
the different T-cell subpopulations
(CD4þ versus CD8þ , T helper 1
(Th1) versus Th2 versus Th17; T-reg-
ulatory (T-reg) cells) deserve particular
attention. In addition, it is now clear
that dendritic cells (DCs) and keratino-
cytes are critical elements in the
regulation of skin pathology in AD,
and eosinophils may aggravate the
inflammatory reaction.
An additional emphasis is placed on
the role of specific IgE and T cells as
well as the antigens that are recognized
by these adaptive elements of the
immune system.
IMMUNOHISTOLOGY
Asymptomatic skin in AD differs from
normal skin: The underlying barrier
defect is associated with filaggrin loss-
of-function mutations in more than
30% of patients with AD. This finding
was first published by Palmer et al.
(2006) and then confirmed by several
other groups (see reviews: Brown and
McLean, 2009; O’Regan and Irvine,
2008). The filaggrin loss-of-function
mutations are thought to lead to dry
skin associated with a greater skin
response to irritants than that of normal
healthy skin. Microscopic studies re-
vealed a sparse perivascular T-cell
(Th2) infiltrate in unaffected AD skin
that is not seen in normal healthy skin
(Leung et al., 1983). Mast cell numbers
are also slightly enriched in asympto-
matic skin.
Acute skin lesions are characterized
by intensely pruritic, erythematous
papules associated with excoriation
and oozing exudation in AD. There is
a marked infiltration of mononuclear
cells that is histologically similar to that
in allergic contact dermatitis.
CD4-positive Th cells dominate the
cellular infiltrate in AD (Zachary et al.,
1985). The CD4/CD8 ratio of dermis-
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infiltrating T cells is similar to that in
peripheral blood. Many intralesional T
cells show signs of activation and can
further be distinguished by CD45RO, a
marker of T-memory cells, suggesting a
previous contact with antigen or aller-
gen, and by the cutaneous lymphocyte-
associated antigen (CLA). CLA defines
the subset of skin-homing T cells that
bind to E-selectin, an adhesion mole-
cule expressed by endothelial cells in
inflamed tissues during the first step of
leukocyte extravasation (Picker et al.,
1990; Santamaria Babi et al., 1995).
Many circulating CLAþ T cells display
a Th2 phenotype and some are allergen
specific (Akdis et al., 1997). IL-12
appears to be a key cytokine in the
regulation of CLA; CLA-negative Th2
cells rapidly upregulate a(1-3)-fucosyl-
transferase VII (involved in the expres-
sion of CLA) and CLA molecules
(Biedermann et al., 2006).
Mononuclear cells and eosinophil
granulocytes can be found mainly in
the dermis (Van Reijsen et al., 1992).
Mast cell degranulation can be ob-
served in acute lesions. Antigen-pre-
senting cells in lesional and, to a lesser
extent, in nonlesional skin bear IgE
molecules (Bieber, 2007; Novak et al.,
2007).
Chronic inflammation generally
causes tissue remodeling, which is also
observed in chronic lesions of AD. This
can be observed as thickened plaques
with increased skin markings (lichenifi-
cation), increased collagen deposition in
the dermis, and dry fibrotic papules.
Dermal macrophages are markedly in-
creased in the dermal infiltrate during
the chronic phase. Intact eosinophils are
less commonly found, but eosinophilic
products can be identified in chronic
lesions of AD. T cells remain present in
the chronic phase, although in smaller
numbers than seen in acute AD.
Taken together, both asymptomatic
skin and the different stages of eczema
are associated with the infiltration of
leukocytes (mainly T cells) that char-
acterizes the histology of this disease.
EARLY EVENTS IN AD
DEVELOPMENT
Early events initiating atopic skin in-
flammation involve mechanical trauma
and skin barrier disruption, which may
occur after the skin is scratched. This
results in the rapid upregulation of
proinflammatory mediators such as IL-
1a, IL-1b, TNF-a, and GM-CSF (Homey
et al., 2006). These proinflammatory
cytokines bind to receptors on the
vascular endothelium, activate cellular
signaling, and induce the expression of
vascular endothelial cell adhesion mo-
lecules. These events initiate the pro-
cess of adhesion to the endothelium,
tethering, and transmigration of infil-
trating cells. This process is tightly
regulated and involves an active
communication process between
endothelial cells and leukocytes. T
cell–endothelial cell interactions are
thus crucial in acute AD. In addition,
there is crosstalk between endothelial
cells and other cutaneous cells, such as
mast cells and perivascular dermal
macrophages (Steinhoff et al., 2006).
Once inflammatory cells have infil-
trated into the tissue, they respond to
chemotactic gradients established by
cytokines and chemokines, which ori-
ginate from sites of injury or infection.
These molecules play a central role in
defining the nature of the inflammatory
infiltrate in AD. For example, IL-16
produced by Langerhans cells (LCs)
may help in the recruitment of T cells
and has been reported in AD lesions
(Reich et al., 2002). Several homeo-
static and inflammatory chemokines,
including CCL2 (MCP-1), CCL5
(RANTES), CCL17 (TARC), CCL18
(PARC), CCL29 (LARC), CCL22
(MDC), and CCL27 (CTACK), have
been shown to be increased in AD
and thus may support leukocyte re-
cruitment (Homey et al, 2006). Of note,
cutaneous T-cell-attracting chemokine
(CCL27) is significantly upregulated in
AD and preferentially attracts cuta-
neous lymphocyte antigen-positive T
cells into the skin. Selective recruit-
ment of CCR4-expressing Th2 cells is
mediated by macrophage-derived che-
mokine (CCL22) and thymus and acti-
vation-regulated cytokine (CCL17),
which are increased in patients with
AD. Interestingly, serum levels of a
number of chemokines (for example,
CCL17, CCL22, and CCL27) correlate
with disease activity, suggesting an
important role in the pathogenesis of
AD (Homey et al., 2006).
The maintenance of chronic AD
involves the production of GM-CSF
and the Th1-like cytokines IL-12 and
IL-18 (Hamid et al., 1994), as well as
several remodeling-associated cyto-
kines, such as IL-11 and TGF-b1, which
are expressed preferentially in chronic
forms of the disease (Toda et al., 2003).
In summary, early events include
endothelial–T-cell interaction and the
release of chemokines—the under-
standing of these events is of particular
importance for a recurrent disease such
as AD.
T-LYMPHOCYTES
CD4þ and CD8þ T cells in AD
Patients suffering from AD have in-
creased levels of activated circulating
T cells. A study revealing increased
telomerase activity and shortened telo-
mere length in AD indicates that T cells
are chronically stimulated and have an
increased cellular turnover in vivo (Wu
et al., 2000).
The high number of circulating T
cells results from increased numbers of
CD4þ cells, whereas the absolute
number of CD8þ lymphocytes is
normal or even decreased in peripheral
blood. However, acute psychological
stress has been shown to lead to rapid,
significantly higher increases in the
number of circulating CD8þ T-lym-
phocytes in AD patients compared with
healthy controls. This may indicate that
there are larger pools of this cell type
close to the circulation that can be
translocated into the blood during
psychological stress (Schmid-Ott
et al., 2001a).
The role of CD8þ T cells in atopic
skin inflammation is still not well
defined. It has been shown that CLAþ
CD8þ T cells isolated from the circu-
lation are as potent as CLAþ CD4þ T
cells in the induction of IgE and
enhancement of eosinophil survival.
This suggests that these cells have more
than bystander functions in AD (Akdis
et al., 1999). Later, a significant asso-
ciation between the frequency of aller-
gen-specific (that is, Der p 1-specific)
CD8þ T cells and disease activity
was described (Seneviratne et al.,
2002). Recent data from a mouse
model indicate that allergen-primed
CD8þ T cells are required for the
www.jidonline.org 1879
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development of AD-like lesions in vivo
(Hennino et al., 2007).
In summary, although CD4þ cells
clearly dominate over CD8þ cells in
the skin in AD, there is some evidence
that CD8þ cells are also of relevance
in this disease.
T-cell cytokines in AD. The onset of
acute AD is strongly associated with
the production of Th2 cytokines, nota-
bly IL-4, IL-13, and IL-31, levels of
which are significantly higher in AD
individuals compared with control sub-
jects (Hamid et al., 1994; Neis et al.,
2006).
Th1 and Th2 cytokines may contri-
bute to the pathogenesis of local skin
inflammation in AD with the relative
contribution of each cytokine dependent
on the duration of the skin lesion. In
previous studies, the majority of aller-
gen-specific T cells derived from skin
lesions that had been provoked by
epicutaneous application of inhalant
allergens were found to produce pre-
dominantly Th2 cytokines such as IL-4,
IL-13, or IL-5. This was initially consid-
ered to be a specific feature reflecting
immune dysregulation in AD (Sager
et al., 1992; Van Reijsen et al., 1992).
It was subsequently shown that the
expression of IFN-g rather than of IL-4
predominates in spontaneous or older
patch test lesions in AD (Grewe et al.,
1995; Thepen et al., 1996). Importantly,
patient treatments that resulted in lesion
improvement could be correlated with
downregulation of IFN-g expression, but
not of IL-4, in the skin (Grewe et al.,
1995). Also, allergen-specific T-cell
clones from spontaneous AD lesions
differed from allergen-specific T cells
isolated from inhalant allergen patch test
lesions by virtue of their capacity to
produce IFN-g (Werfel et al., 1996).
The cytokine switch from Th2 in the
acute phase toward Th1 in the chronic
phase is accepted for AD and appears
to be relevant in allergic contact
dermatitis as well.
Factors contributing to cytokine milieu
in AD. In patients with AD, activated T
cells with skin-homing properties,
which express high levels of IFN-g,
may predominantly undergo apoptosis
in the circulation, skewing the immune
response to surviving Th2 cells as a
mechanism for Th2 predominance in
the circulation and in acute lesions
(Akdis et al., 2003; Akkoc et al.,
2008). Moreover, patients with AD
have a genetic background of a
general systemic Th2 polarization
(Brown and McLean, 2009), which
contributes to the higher number of
circulating T cells capable of producing
Th2 cytokines.
IL-4, which is a strong inducer of a
type 2 cytokine milieu itself, is pro-
duced by ‘‘early’’ skin-infiltrating T
cells, but it may also come from mast
cells, basophils, or eosinophils during
an acute eczematous skin reaction. It is
interesting to note that the high fre-
quency of IL-4-producing T cells in the
skin is not necessarily associated with
atopy given that mRNA for IL-4 and T
cells expressing IL-4 are also found in
nickel-induced patch test reactions
(Neis et al., 2006; Szepietowski et al.,
1997; Werfel et al., 1997b).
Acute lesions show a reduced expres-
sion of IL-12, a key cytokine of Th1
polarization, which was shown at the
mRNA level by in situ hybridization in
acute skin lesions (Hamid et al., 1996).
The reason for the relative lack in the
expression of IL-12 is not completely
understood. sCD40L was shown to
inhibit IL-12 upregulation by an intracel-
lular ERK-dependent signal-transducing
pathway (Wittmann et al., 2002). These
results were reproduced later and ex-
tended to skin-infiltrating CD40Lþ T
cells, which may thus contribute to the
relative inability to upregulate IL-12 in
acute eczema, leading to a refractory
state of constitutive antigen-presenting
cells (Wittmann et al., 2004).
A number of factors may be in-
volved in the switch from Th2 to Th1
cytokines in older lesions. The polar-
ization of T cells along the Th1 lineage,
resulting in IFN-g production, is sup-
ported by IL-12, IL-23, IL-27, and IL-18
(Hunter, 2005). IL-12 subunits have
been found to be expressed by anti-
gen-presenting cells and by human
keratinocytes. However, it is not clear
whether keratinocytes are indeed a
relevant source of bioactive IL-12.
IL-23 has recently been shown to be
produced by DCs and by human
cultured keratinocytes in healthy skin
and in psoriasis—its role in AD has to
be defined (Piskin et al., 2006). Inter-
action with activated T cells via
CD40–CD40L may enhance IL-23 pro-
duction by keratinocytes, which may
enhance IFN-g production by memory
T cells (Wittmann and Werfel, 2006).
IL-18 is another cytokine that func-
tions in parallel with IL-12 (Dinarello,
2007). Keratinocytes functionally re-
spond to IL-18 with upregulation of
major histocompatibility class (MHC) I,
reinforcement of the IFN-g-induced
MHC class II expression, and produc-
tion of the chemokine CXCL10 (Witt-
mann et al., 2005). This supports the
notion that IL-18 is involved in the
pathogenesis of local Th1 responses in
chronic inflammatory skin diseases.
The molecular mechanism of the
cytokine switch from Th2 in the acute
phase to Th1 in the chronic phase is
complex and involves different Th2
cytokine-producing cells in the acute
phase (for example, T cells, basophils,
mast cells) and Th1-polarizing cyto-
kines, which are produced primarily by
antigen-presenting cells.
Effects of T-cell cytokines on the
inflammatory reaction in the skin in
AD. In lymphoid organs, IL-4 and IL-13
mediate the IgE isotype switch in B
cells. In acute eczema, IL-4 and IL-13
induce a variety of local responses,
such as the induction of the adhesion
molecules on endothelial cells and Fc
receptors on eosinophils or chemo-
kines (Leung et al., 2004). In contrast
to IL-5, IL-4 induces apoptosis in
eosinophils (Wedi et al., 1998).
Recent findings demonstrate that IL-
4 and IL-13 have effects on keratino-
cytes: both cytokines function via the
same receptor (Purwar et al., 2007b).
IL-13- or IL-4-stimulated keratinocytes
attract CCR4þ CD4þ Th2 cells via
CCL22 (Purwar et al., 2006). Moreover,
IL-13 induces the expression of MMP-9
in keratinocytes (Purwar et al., 2007a),
which may play a crucial role in atopic
skin inflammation by facilitating the
migration of leukocytes into the epi-
dermis.
Some AD patients have a filaggrin
loss-of-function mutation leading to
reduced filaggrin expression in the skin
(Brown and McLean, 2009). Recently it
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was shown that filaggrin expression
was reduced in AD even in the absence
of a loss-of-function mutation (Howell
et al., 2007). Keratinocytes differen-
tiated in the presence of IL-4 and IL-13
exhibited significantly reduced filag-
grin gene expression compared with
medium alone. Neutralization of IL-4
and IL-13 may improve skin barrier
integrity (Howell et al., 2007). This
indicates that the atopic immune re-
sponse directly contributes to the skin
barrier defect in AD.
A ‘‘new’’ Th2-associated cytokine,
IL-31, has been shown to be highly
expressed in acute eczema (that is, in
both acute atopic and acute allergy
contact dermatitis) (Neis et al., 2006).
IL-31 is produced by T cells that
express CLA and localize to the skin
(Bilsborough et al., 2006). It appears to
be a link between skin-infiltrating T
cells and pruritus in the skin, as
demonstrated in a mouse model (Ta-
kaoka et al., 2006). In humans, IL-31 is
significantly overexpressed in itching
skin inflammation such as AD (Sonkoly
et al., 2006; Raap et al., 2008).
Staphylococcal superantigens and his-
tamine induce IL-31 expression in
atopic individuals (Gutzmer et al.,
2009). These data suggest that IL-31
may be an itch-causing mediator in
patients with AD derived from skin-
infiltrating T cells.
In chronic lichenified AD skin le-
sions, fewer IL-4 and IL-13 mRNA-
expressing cells are present, but greater
numbers of IL-5, GM-CSF, IL-12, and
IFN-g mRNA-expressing cells are de-
tected (Hamid et al., 1994). The rise in
IL-5 expression during the transition
from acute to chronic AD probably
plays a role in the prolongation of
eosinophil survival and function (Wedi
et al., 1999). Some of the other
cytokines mentioned above support
the function of macrophages and pro-
mote the Th1-type inflammation more
characteristic of chronic AD (Fiset
et al., 2006). Effects of IFN-g on
keratinocytes are discussed below.
In summary, T-cell cytokines have
numerous effects on skin inflammation,
ranging from the induction of chemo-
kines and downmodulation of barrier-
associated molecules to the induction
of pruritus.
Th17 lymphocytes in AD
Recently, a novel and unique subset of
IL-17-producing CD4þ Th17 cells, dis-
tinct from Th1 and Th2 cells, was
discovered. Th17 cells appear to be
involved in protection against bacterial
pathogens. In addition, Th17 cells may
also be crucial in the pathogenesis of
various chronic inflammatory diseases
that were formerly categorized as Th1-
mediated disorders. Whereas IL-17 may
play an important role in the pathogen-
esis of psoriasis and contact hypersensi-
tivity, its role in AD is still under
investigation (van Beelen et al., 2007).
In skin biopsy specimens recovered from
acute and chronic skin lesions from
patients with AD, IL-17 mRNA was
preferentially associated with acute le-
sions (Toda et al., 2003). In a recent
study, the percentage of Th17 cells was
shown to be higher in the peripheral
blood of AD patients and associated with
the severity of AD. Immunohistochemi-
cally, IL-17þ cells infiltrated the papil-
lary dermis of atopic eczema more
markedly in acute lesions than in chronic
lesions (Koga et al., 2008).
Epicutaneous immunization with
ovalbumin, which causes allergic skin
inflammation with many characteristics
of the skin lesions of AD in a mouse
model, was found to drive IL-17
expression. Epicutaneous, but not in-
traperitoneal, immunization of mice
with ovalbumin drove the generation
of IL-17-producing T cells in both the
spleen and the draining lymph nodes
and increased serum IL-17 levels. DCs
trafficking from skin to lymph nodes
expressed more IL-23 and induced
more IL-17 secretion by naive T cells.
This was inhibited by neutralizing IL-23
in vitro and by intradermal injection of
anti-TGF-b-neutralizing antibody
in vivo. These data suggest that initial
cutaneous exposure to protein antigens
may selectively induce the production
of IL-17 in AD (He et al., 2007).
Taking together these findings, Th17
cells are present in the skin of AD. The
role of these cells in acute eczema for the
course of AD remains to be elucidated.
T-reg cells in AD
T-reg cells control the activation of
autoreactive and T-effector cells and
are crucial for the maintenance of
peripheral tolerance to self-antigens.
CD4þ Foxp3þ T-reg cells have been
referred to as ‘‘naturally occurring’’ T-
reg cells to distinguish them from
adaptive T-reg cells, which are gener-
ated upon activation. A major popula-
tion of adaptive T-reg cells is
characterized by the secretion of high
levels of IL-10 or transforming growth
factor (Akdis et al., 2005). Mutations in
FOXP3, a nuclear factor expressed in
natural T-reg cells and a subpopulation
of adaptive T-reg cells, result in im-
mune dysregulation polyendocrinopa-
thy enteropathy X-linked syndrome
characterized by hyper-IgE, food al-
lergy, and eczema (Torgerson and
Ochs, 2007), which suggests a possible
role of T-reg cells in AD.
Increased numbers of peripheral
blood CD4þ CD25þ T cells and an
overexpression of FOXP3 have been
found in the blood of AD patients
compared with psoriasis patients and
healthy controls (Ou et al., 2004).
Staphylococcal enterotoxin B inhibits
natural T-reg cells in vitro (Ou et al.,
2004). Superantigens have been shown
to upregulate glucocorticoid-induced
TNF-receptor-related protein ligand on
monocytes, resulting in the prolifera-
tion of natural T-reg cells and abroga-
tion of their immunosuppressive
activity (Cardona et al., 2006).
In the skin, adaptive T-reg cells, but no
FOXP3þ natural T-reg cells, were de-
tectable in AD in a series of biopsies from
eight AD patients (Verhagen et al., 2006).
However, in recent studies, the numbers
of FOXP3þ natural T-reg cells were
similar or higher in AD patients com-
pared with healthy controls (Franz et al.,
2007; Schnopp et al., 2008). It is
noteworthy that the number of natural
T-reg cells did not change significantly
after medium-dose UVA-1 radiation
(Schnopp et al., 2007).
In summary, most recent studies have
identified T-reg cells in the skin of AD
patients. It remains to be determined
whether the differences in functional
activities of T-reg cells shown in vitro
are relevant for the course of AD in vivo.
DCs
Myeloid DCs in AD
DCs are specialized antigen-presenting
cells found in lymphoid tissues and in
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peripheral organs such as the skin.
Two major subtypes of DCs have
been shown to play an important
role in the pathophysiology of AD
in humans: myeloid DCs and plasma-
cytoid DCs (pDCs) (Novak et al.,
2007).
Myeloid DCs can be further differ-
entiated into two subtypes that
have been found in lesional skin of
AD patients: LCs and inflammatory
dendritic epidermal cells (IDECs).
Both LCs and IDECs express the
high-affinity receptor for IgE (FceRI)
(Bieber, 2007), but they have different
functions in AD. LCs play a predomi-
nant role in the initiation of the
allergic immune response and prime
naive T cells into T cells of the Th2 type
with high IL-4-producing capacity,
which predominate in the initial
phase of AD (Novak et al., 2004).
Activated LCs can also present aller-
gen-derived peptides to antigen-speci-
fic T cells in the skin. The aggregation
of FceRI on the surface of LCs induces
the release of chemotactic factors (for
example, CCL2, CCL22, CCL17, or IL-
16) and may facilitate allergen presen-
tation to T cells (Maintz and Novak,
2007).
IgE-bearing FceRIþ IDECs become
more prominent in chronic AD lesions.
After allergen challenge, invasion of
high numbers of IDECs has been
shown, emphasizing their crucial
role in the development of eczema
(Kerschenlohr et al., 2003). IDECs are
also found exclusively at inflammatory
sites, suggesting an involvement
in cell recruitment and IgE-mediated
antigen presentation to T cells. In
contrast to LCs, these cells promote
Th1 cytokine production from T cells.
In this context it has been shown
that stimulation of FceRI on the surface
of IDECs induces the release of IL-12
and IL-18. This may contribute to the
switch from the initial Th2 immune
response in acute AD to the Th1
polarization of T cells in the chronic
phase (Novak et al., 2004).
In summary, both resident and
infiltrating myeloid DC populations
are crucial in AD. The expression of
Fc receptors for IgE on these cells may
be of importance for facilitated allergen
presentation in AD.
pDCs
Activated pDCs are able to produce
antiviral type I interferons. pDCs in the
peripheral blood of patients with AD
have been shown to bear the trimeric
variant of FceRI on their cell surface,
which is occupied by IgE molecules.
pDCs can take up allergens by FceRI-
IgE, process them, and promote Th2-
type immune responses (Novak et al.,
2007). Increased numbers of pDCs
have been found in the peripheral
blood of AD patients, but only low
numbers of pDCs are detectable in skin
lesions in AD, in contrast to other
inflammatory skin diseases (Wollen-
berg et al., 2002).
The lack of pDCs in the skin has
been shown to contribute to the high
susceptibility of AD patients to viral
skin infections, such as herpes simplex-
induced eczema herpeticum.
KERATINOCYTE–T-CELL
INTERACTIONS
There is growing evidence supporting
keratinocytes as enhancer cells of the
inflammatory response in AD (Witt-
mann and Werfel, 2006; Holgate,
2007). Keratinocytes play a role in
innate immunity by expressing Toll-like
receptors and producing antimicrobial
peptides in response to invading mi-
crobes (McGirt and Beck, 2006; De
Benedetto et al., 2009).
Keratinocytes secrete a unique pro-
file of chemokines and cytokines after
exposure to proinflammatory cytokines
(Figure 1A and B). Keratinocyte-derived
thymic stromal lymphopoietin (TSLP)
may be of particular importance in AD
(Soumelis and Liu, 2004; Homey et al.,
2006): This protein is not detected in
normal skin or in nonlesional skin in
patients with AD, but it is highly
expressed in lesions in both acute and
chronic AD. TSLP instructs human DCs
to create a Th2-permissive microenvir-
onment by inducing the expression of
OX40L, which triggers the differentia-
tion of inflammatory Th2 cells (Ito
et al., 2005). Recently it was shown
that TSLP, synergistically with IL-1 and
TNFa, stimulates the production of
high levels of Th2 cytokines by human
mast cells. In that study, TSLP was
shown to be released by primary
epithelial cells in response to microbial
products, physical injury, or inflamma-
tory cytokines (Allakhverdi et al.,
2007). Moreover, a recent paper de-
monstrated a strong link between TSLP
and skin barrier disruption (Demehri
et al., 2008).
The general role of chemokines in
the initiation and perpetuation of AD
has been reviewed by Homey et al.
(2006). Keratinocytes stimulated with
proinflammatory cytokines have been
identified as an important cellular
source of chemokines, which attract T
cells of different subtypes (Wittmann
and Werfel, 2006). For example,
CXCR3 ligands such as CXCL10 pre-
ferentially attract Th1 cells (Albanesi
et al., 2001). CCL22 and CCL17 pre-
ferentially attract Th2 cells by binding
to CCR4 (Purwar et al., 2006). CCL2 is
effective on both Th1 and Th2 subsets.
CCL27, which is constitutively ex-
pressed by keratinocytes, binds to
CCR10 expressed on most skin-homing
lymphocytes (Homey et al., 2002).
Keratinocytes are also important
cellular sources of cytokines such as
the T-cell growth factor IL-15 in the
skin (Han et al., 1999) (Figure 1B). IL-
15 has been implicated in the patho-
genesis of different skin diseases by
virtue of its action on the maintenance
of T cells—possibly intraepithelial
T cells.
Keratinocytes respond to both Th1
and Th2 cytokines from T cells (Figure
1C). Among them, IFN-g is one of the
most potent keratinocyte-activating
factors. It induces surface molecules
(for example, ICAM-1, MHC class I and
II, CD40, and Fas), chemokines (for
example, CCL2, CCL3, CCL4, CCL5,
CCL18, CCL22, and CXCL10) and
cytokines (for example, IL-1, IL-6, IL-
18, and TGF-b) in keratinocytes. Many
other molecules, such as matrix metal-
loproteinases, growth factors, enzymes,
and transcription factors/pathway
molecules, are also upregulated.
(Homey et al., 2006; Wittmann and
Werfel, 2006). Pastore et al. (1998,
2000) observed differences in the re-
sponsiveness to cytokines of keratino-
cytes from AD patients as compared
with healthy controls or psoriasis pa-
tients (Giustizieri et al., 2001).
It has been shown that IFN-g in-
duces Fas on keratinocytes, which
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renders them susceptible to apoptosis
induction by infiltrating FasLþ T cells
(Trautmann et al., 2000). This has been
interpreted as an important event in
eczema, mainly in AD. There is further
evidence that cleavage of E-cadherin
and sustained desmosomal cadherin
contacts between keratinocytes that
are undergoing apoptosis result in
spongioform morphology in the epider-
mis. This morphology is regarded as a
hallmark of eczematous lesions (Traut-
mann et al., 2001). Suppression of
keratinocyte activation and apoptosis
thus remains a potential target for the
treatment of AD (Akdis et al., 2006).
Both CXCR3þ CD4þ and CCR4þ
CD4þ T cells migrate in response to
IFN-g-treated human primary keratino-
cytes (Purwar et al., 2006). It is inter-
esting to note that IFN-g also induces
CCL22 production in human keratino-
cytes. Many IFN-g-inducible molecules
are reinforced by IL-4 or IL-13 in
human keratinocytes, such as CD54,
CCL2, CCL5, and CXCL10 (Albanesi
et al., 2000; Purwar et al., 2006).
Keratinocytes have been shown to
express the IL-1 and IL-33 receptor,
ST2, in the acute phase of eczema in
AD. A significant genetic association
between AD and a single-nucleotide
polymorphism has been found in the
distal promoter region of the ST2 gene
(Shimizu et al., 2005). This polymorph-
ism is associated with an upregulation
of the transcriptional activity of the ST2
gene. The ligand of ST2, IL-33, induces
the expression of IL-4, IL-5, and IL-13
in vivo, which may explain higher IgE
serum levels found in patients with the
ST2 polymorphism in AD.
Taken together, these observations
suggest that keratinocytes are important
regulatory and effector cells in skin
diseases involving the epidermis as a
particular feature.
EOSINOPHILS
Eosinophils play an important role in
AD, characterized by activated eosino-
phils in the peripheral blood and in the
lesional skin (Leiferman et al., 1985;
Kapp, 1993; Simon et al., 2004).
Increased numbers of circulating eosi-
nophils are frequently observed in
patients with AD. Inhibition of eosino-
phil apoptosis in AD, probably
mediated by IL-5 and GM-CSF, appears
to be a relevant mechanism for the
eosinophil accumulation observed in
AD (Wedi et al., 1999). Interestingly,
acute psychosocial stress leads to
further increases in eosinophil counts
and IL-5þ T cells in the peripheral
blood (Schmid-Ott et al., 2001a, b).
Eosinophils are recruited to tissue
sites mainly by chemokines (for exam-
ple, eotaxin and RANTES (regulated on
activation, normal T-cell expressed and
secreted)). A survey on the chemokine
receptor repertoire of human peripheral
T cellCCL2/MCP-1
CCL18/PARC
CXCL10/IP-10
CCL5/RANTES
CCL22/MDC
CCL27/CTACK
IL-1 IL-27
IL-8
IL-18
IFN-γ IL-4
IL-13
Keratinocytes attract T cells
by chemokine production
a
b
c
Keratinocytes
Keratinocytes stimulate skin-infiltrating
T cells via cytokines
T cells stimulate keratinocytes
via cytokines
IL-23
Figure 1. Keratinocyte–T-cell interactions. (a) Keratinocytes attract T cells by chemokine production. (b)
Keratinocytes stimulate skin-infiltrating T cells via cytokines. (c) T cells stimulate keratinocytes via
cytokines.
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blood eosinophils draws a confusing
picture of receptors (Homey et al.,
2006). However, the expression of
CCR3 on eosinophils seems to be of
particular importance; a number of
findings suggest that CCR3-driven path-
ways are essential for the recruitment of
eosinophils to sites of atopic skin
inflammation (Hoechstetter et al.,
2000). In the skin lesions of AD,
CCR3 ligands are candidates that med-
iate the influx of eosinophils into the
skin (Gombert et al., 2005).
The interaction of eosinophil
surface molecules with endothelial
cell vascular cell adhesion molecule 1
and intercellular adhesion molecule 1
are important for eosinophil extravasa-
tion and activation. Activated eosino-
phils are capable of releasing a variety
of potent cytotoxic granule proteins
and chemical mediators contributing
to tissue inflammation (Elsner and
Kapp, 1999), as shown by the deposi-
tion of eosinophil products in the
inflamed skin (Bruijnzeel-Koomen
et al., 1992).
Eosinophils play a relevant role in
neuroimmunologic interactions—en-
hanced levels of brain-derived growth
factor can be detected in the sera and
plasma of patients with AD. Brain-
derived growth factor has been shown
to reduce eosinophil apoptosis while
enhancing chemotaxis of eosinophils
in vitro (Raap et al., 2006).
In summary, eosinophils infiltrate
the skin of AD patients and aggravate
the inflammatory response.
DEFECTS IN THE INNATE IMMUNE
RESPONSE IN AD
Most patients with AD are colonized
with Staphylococcus aureus and ex-
perience exacerbation of their skin
disease after infection with this organ-
ism (De Benedetto et al., 2009). In
patients with AD with bacterial infec-
tion, treatment with anti-staphylococ-
cal antiseptics and antibiotics can
result in the improvement of skin
lesions (Breuer et al., 2002). Binding
of S. aureus to skin is enhanced by AD
skin inflammation. This is supported by
clinical studies demonstrating that
treatment with topical corticosteroids
or tacrolimus reduces S. aureus counts
in AD.
Recent evidence suggests that a
deficiency of the antimicrobial pep-
tides dermcidin, cathelicidin LL-37,
human b-defensin (HBD)-2, and HBD-
3 contributes to the susceptibility of
atopic patients to skin infections
(McGirt and Beck, 2006). Defensins
are broad-spectrum antibiotics that kill
bacterial and fungal pathogens. LL-37
has been shown to display antimicro-
bial activity against viral pathogens in
addition to bactericidal and fungicidal
actions (Howell et al., 2006). The
expression of antimicrobial peptides
by keratinocytes is increased in re-
sponse to inflammatory cytokines.
However, IL-4 and IL-13 have been
shown to downregulate the expression
of b-defensins and of LL-37 in the skin
in AD (Ong et al., 2002; Nomura et al.,
2003; Howell et al., 2006). This can
predispose to S. aureus colonization
and to severe eczema herpeticatum.
Recently it was shown that mono-
cytes from AD patients are functionally
defective in their ability to produce
proinflammatory cytokines on Toll-like
receptor 2 stimuli (Hasannejad et al.,
2007; Niebuhr et al., 2009). Moreover,
Toll-like receptor 2 with a single-
nucleotide polymorphism was found
in higher frequency in patients with
severe AD compared with control
groups (Ahmad-Nejad et al., 2004).
Cells with this polymorphic Toll-like
receptor 2 show altered responses to
peptidoglycans and lipoteichoic acid
from staphylococcal cell walls, which
may further contribute to the innate
immune defect in AD (Niebuhr et al.,
2008 and Mrabet-Dahbi et al., 2008).
Patients with the head and neck
variant of AD are frequently colonized
with Malassezia species (Scheynius
et al., 2002). Malassezia sympodialis
cells produce, express, and release
allergens to a greater extent when
cultured at the higher pH resembling
the high pH in the skin of AD. This was
particularly true of the major allergen
Mala s 12, suggesting that the skin
barrier in AD patients provides an
environment that can enhance the
release of allergens from M. sympodia-
lis, which can in turn contribute to the
inflammation (Selander et al., 2006).
Together, these findings indicate
that a number of constitutive and
acquired defects of innate immunity
may explain the predisposition of the
skin in AD to bacterial, viral, or fungal
infection or colonization.
IgE IMMUNOREACTIVITY
In approximately 80% of adult patients
with AD, the disease is associated
with increased serum IgE levels
(4150 kU l1), sensitization to aeroal-
lergens and food allergens, and/or
concomitant food allergy, allergic rhi-
nitis, and asthma (Werfel and Kapp,
1998; Leung et al., 2004). Recent
epidemiologic data suggest a contribu-
tory role for IgE-mediated immunologic
processes in the onset and course of
AD, especially in patients with severe
disease. (Williams and Flohr, 2006).
However, 20% of adult patients
with eczematous skin lesions clinically
and histologically indistinguishable
from AD lack sensitization and other
clinical manifestations of the atopic
diseases. This subtype of AD often has
a late onset (420 years of age) and a
lack of IgE sensitization to inhalant or
food allergens (Werfel and Kapp, 1999;
Novak and Bieber, 2003). In children, a
transient form of AD with low IgE
serum levels and without any detect-
able sensitization has been observed; it
develops into the extrinsic variant of
AD with increasing IgE serum levels
and development of sensitization to
aeroallergens and food allergens later
in life (Novembre et al., 2001).
Despite the clinical similarity,
AD patients with IgE-mediated allergy
exhibit higher tissue eosinophilia,
enhanced lesional cytokine expression,
and higher surface expression of the
FceRI on epidermal DCs compared
with non-allergic eczema patients.
Specific IgE may play a critical role
in cutaneous inflammation in the
activation of mast cells and DCs via
high-affinity Fc receptors (Bieber,
2007). IgE-mediated histamine release
from cutaneous mast cells may aggra-
vate AD through the itch–scratch cycle.
Moreover, increased cutaneous inflam-
mation, mediated via histamine recep-
tors, on T-lymphocytes (Jutel et al.,
2001; Gutzmer et al., 2009), antigen-
presenting cells (Gutzmer et al., 2005;
Gutzmer et al., 2005; Dijkstra et al.,
2007), and keratinocytes (Giustizieri
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et al., 2004) is probable. IgE-facilitated
allergen presentation by DCs and
activation of DCs via high-affinity Fc
receptors in the skin are discussed
above (Bieber, 2007).
Despite many in vitro and ex vivo
findings, the importance of IgE to the
clinical severity of AD is difficult to
evaluate. In a recent study of adult
patients with AD, it became clear that
patients with greater IgE-mediated sensi-
tization suffer from more severe disease
(Salt et al., 2007). In proof-of-concept
trials, some—but not all—patients trea-
ted with anti-IgE antibodies improved in
terms of eczema severity (Lane et al.,
2006; Vigo et al., 2006; Belloni et al.,
2007; Forman and Garrett, 2007). How-
ever, extremely high total IgE serum
levels in AD present a major problem for
treatment with anti-IgE. A controlled
study with anti-IgE is therefore required
(Beck and Saini, 2006).
In summary, specific IgE not only is
relevant to immediate reactions but
may contribute to delayed eczematous
skin reactions in AD as well.
ALLERGEN-SPECIFIC T CELLS
Primary T-cell immunodeficiency dis-
orders are frequently associated with
high serum IgE levels and eczematous
skin lesions, which clear after success-
ful bone marrow transplantation (Akdis
et al., 2006). In animal models of AD,
the eczematous rash does not occur in
the absence of T cells (Spergel et al.,
1999).
FOOD ALLERGENS
Food allergy and AD may occur in the
same patient. In addition to typical
immediate types of allergic reactions
(that is, noneczematous reactions),
which are observed in AD patients,
foods can provoke flares of AD; this has
been demonstrated in placebo-con-
trolled food challenge studies (Werfel
and Breuer, 2004). The serum levels of
food-specific IgE can be predictive for
the outcome of oral provocation tests
with foods, as observed in cohort
studies with children with AD who
had immediate reactions to foods
(Sampson, 2001; Mehl et al., 2005).
Specific T cells have been shown to be
involved in the late eczematous re-
sponse to food; higher proliferative
responses to food proteins and specific
T-cell clones can be generated from
patients with food-induced eczema
(Reekers et al., 1996; Werfel et al.,
1997a; van Reijsen et al., 1998). In
addition, milk-induced eczema has
been reported to be associated with a
higher rate of CLAþ lymphocytes
upon in vitro stimulation with casein
(Abernathy-Carver et al., 1995).
A murine model of food-induced AD
confirmed the important role of food-
specific T cells in eczema. C3H/HeJ
mice were orally sensitized to cow’s
milk or peanuts and then subjected to
low-grade allergen exposure. An ecze-
matous eruption developed in approxi-
mately one-third of mice after low-grade
exposure to milk or peanut proteins.
Histologic examination of the lesional
skin revealed spongiosis and a cellular
infiltrate consisting of CD4þ lympho-
cytes, eosinophils, and mast cells. IL-5
and IL-13 mRNA expression was ele-
vated only in the skin of mice with the
eczematous eruption (Li et al., 2001).
Patients sensitized to pollen aller-
gens often develop an IgE-response to
cross-reactive food allergens. Con-
sumption of birch pollen-related foods
such as hazelnuts, carrots, apples, and
celery (that is, foods that are cross-
reactive to birch pollen allergens,
mainly the major allergen Bet v1) may
lead to an exacerbation of eczema in a
subpopulation of patients with AD
sensitized to birch pollen antigens. A
birch pollen-specific T-cell response
could be detected in lesional skin of
these responding patients (Reekers
et al., 1999): Birch pollen-related food
may also induce allergic symptoms in a
subgroup of children with AD (Breuer
et al., 2004). Recently, Bohle et al.
(2006) showed that T-cell cross-reac-
tivity between Bet v1 and related food
allergens can occur independent of IgE
cross-reactivity in vitro and in vivo. In
patients with AD, the resulting immune
reaction that manifested as late ecze-
matous skin reactions to cooked food
was shown to elicit T cell- but not IgE-
mediated responses.
In summary, T-cell responses and
specific IgE to food allergens may
explain flare-ups of eczema upon oral
food challenges in sensitized patients
with AD.
AEROALLERGENS
Pruritus and skin lesions can develop after
intranasal or bronchial inhalation chal-
lenge with aeroallergens in patients with
AD. Epicutaneous application of aero-
allergens (house dust mites, weeds, ani-
mal danders, and molds) on
asymptomatic skin of patients with AD
elicits eczematous reactions in a sub-
group of patients with AD. The so-called
atopy patch test has been used in recent
years as a model for studying allergen-
induced changes in the skin of AD
patients (Darsow et al., 2004; Turjanmaa
et al., 2006). Aeroallergen-specific T cells
were first isolated from skin sites from
atopy patch test lesions (Sager et al.,
1992; Van Reijsen et al., 1992). Similar
techniques were applied later to isolate
aeroallergen-specific T cells from sponta-
neous lesional skin (Werfel et al., 1996).
A combination of effective measures
to control house dust mites has been
reported to improve AD, but the
clinical effect varied in different clin-
ical studies (Tan et al., 1996; Holm
et al., 2001; Oosting et al., 2002).
Specific immunotherapy directly ad-
dresses an adaptive mechanism in
hypersensitivity reactions. A recent
meta-analysis of specific immunother-
apy studies revealed positive effects of
subcutaneous immunotherapy in the
majority of studies performed to date
on AD (Bussmann et al., 2006). In the
largest cohort study, subcutaneous im-
munotherapy with mite allergens was
effective in moderate to severe AD
(Werfel et al., 2006). In contrast,
sublingual immunotherapy with mite
allergens, which has recently been
studied in children with AD, was
effective only in patients with mild
eczema (Pajno et al., 2007). During
specific immunotherapy of AD, the
level of the tolerogenic cytokine IL-10
increased in the sera of patients,
whereas the levels of CCL17 and IL-
16 decreased (Bussmann et al., 2007).
In summary, evidence of the clinical
role of adaptive immune responses to
aeroallergens for AD come from atopy
patch tests and therapy studies on
specific immunotherapy.
MICROBIAL ALLERGENS
S. aureus can exacerbate AD by secret-
ing exotoxins. Some of them function
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as superantigens, which stimulate acti-
vation of T cells and MHCþ antigen-
presenting cells, macrophages, or ker-
atinocytes. Major effects elicited by
superantigens are summarized in
Figure 2A. Some patients with AD
produce specific IgE antibodies directed
against staphylococcal superantigens
(Figure 2B), to an extent that correlates
with skin disease severity (Bunikowski
et al., 1999; Breuer et al., 2000).
Superantigens have been shown to
penetrate into the dermis (Skov et al.,
2000), and higher doses have been
shown to induce cutaneous inflamma-
tion when applied to the skin in patch
tests (Strange et al., 1996). Low doses
that do not induce visible clinical
inflammation are still able to amplify
aeroallergen-induced patch test re-
sponses (Langer et al., 2007).
There is increasing evidence that the
opportunistic yeast Malassezia species
is a contributing factor in AD. Several
studies have demonstrated the pre-
sence of specific serum IgE, a positive
skin prick test response, and a positive
patch test response against Malassezia
species in adults with AD (Scheynius
et al., 2002). IgE sensitization to Ma-
lassezia species is specific for patients
with AD; it is not seen in patients with
asthma or allergic rhinitis (Scalabrin
et al., 1999; Schmid-Grendelmeier
et al., 2006).
Within ‘‘non-allergic’’ patients with
atopic eczema, some exhibit IgE
sensitization against microbial anti-
gens, such as S. aureus enterotoxins
and Candida albicans or M. sympodia-
lis antigens (Novak et al., 2003). The
presence of specific IgE to Malassezia
antigens in the non-allergic variant of
AD was confirmed in a recent study
(Casagrande et al., 2006). In a larger
cohort, however, it was found that
antimicrobial IgE antibodies were un-
common in patients with AD with low
IgE levels (Reefer et al., 2007).
In summary, microbial allergens
may worsen the skin condition in AD.
SELF-ALLERGENS
Autoimmunity to human proteins may
also contribute to the pathophysiology
of AD. IgE against autoantigens has
been shown to stimulate type 1 hyper-
sensitivity reactions and DCs (Valenta,
2009). Autoallergens induce the prolif-
eration of CLAþ autoreactive T cells in
the blood, and T-cell clones specific for
autoallergens can be generated from
the skin of patients with AD (Heratiza-
deh et al., submitted). Interestingly,
autoallergen-specific IgE was found as
early as in infancy in AD (Mothes et al.,
2005). Cross-reactivity between in-
haled allergens and autoantigens may
lead to autoimmunity: For example, IgE
against manganese superoxide dismu-
tase (MnSOD) from the skin-colonizing
yeast M. sympodialis cross-reacts with
human MnSOD. Patients with AD
sensitized to human MnSOD have
been shown to also be sensitized
against the M. sympodialis MnSOD
(Schmid-Grendelmeier et al., 2005).
Lens epithelium-derived growth fac-
tor/dense fine speckles 70 kDa protein
(LEDGF/DFS70) is another defined
autoantigen in patients with AD. Auto-
antibodies to this protein have been
found in Japan in approximately 30%
of AD patients. It is located predomi-
nantly in the nucleus of the basal
epidermal cells and translocates into
the cytoplasm during differentiation.
Once in the cytoplasm, LEDGF/DFS70
accumulates in the keratohyalin gran-
ules in the granular layer (Sugiura et al.,
2007).
The role of self-allergens remains to
be elucidated in more detail in future
studies. The concept of AD as an
autoimmune disease has therapeutic
implications and may explain the
chronicity of the disease in ‘‘autoaller-
gic’’ patients.
CONCLUSION
Immunological responses to defined
allergens, inflammatory reactions to
microbial agents, and a complex inter-
play of cells and mediators belonging
to the skin immune system contribute
to the clinical appearance of AD.
Allergens may reach the skin from the
bloodstream or through the epidermis,
as depicted in Figure 3. Specific IgE,
which is bound to Fc receptors on DCs
(LC, IDECs, dermal DCs) and on
cutaneous mast cells, may facilitate
allergen presentation to specific T cells
(Th2 cells in the acute phase, Th1 cells
in the chronic phase). Figure 3 high-
lights only some key mediators of AD—
the Th2 cytokine IL-4 and histamine in
the acute phase and Th1-related cyto-
kines IL-12 and IL-18 in the chronic
phase. A number of other mediators are
currently being investigated, with IL-17
and IL-31 representing extensively
studied cytokines with regard to AD at
present. More knowledge of these
factors may contribute to the develop-
ment of specific approaches for phase-
dependent therapies in this chronic
relapsing skin disease.
T cell
T cell
TCR
TCR Specific
IgE
Induction
of
specific IgE
IL-2
IL-4
IL-13
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•
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Induction of T-cell proliferation
Induction of IL-2, IL-5, IL-13 and
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Figure 2. Function of staphylococcal exotoxins as superantigens or as allergens. Staphylococcal
exotoxins can function as superantigens as depicted on the upper part of the figure. In this way exotoxins
induce strong effects on both T cells and antigen-presenting cells, as summarized in the gray box.
Exotoxins can also function as allergens in atopic dermatitis (depicted in the lower part of the figure)
inducing specific IgE and specific Th2 responses.
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